LAVINIA CLINIC LIMITED

LAVINIA CLINIC LIMITED
Contents Page
For the year ended 28 February 2026

Company Information	1
Director's Report	2
Income Statement	3
Statement of Financial Position	4

LAVINIA CLINIC LIMITED
Company Information
For the year ended 28 February 2026

Director	Bilal BASEL
Registered Number	15513621
Registered Office	68a Maryland Hatfield AL10 8DU

1

LAVINIA CLINIC LIMITED
Director's Report
For the year ended 28 February 2026

The director presents his/her/their report and accounts for the year ended 28 February 2026.

The company is dormant and has not traded during the year.

Director

The director who served the company throughout the year was as follows:

Bilal BASEL

On behalf of the board.

----------------------------------
Bilal BASEL
Director

Date approved: 28 August 2026

2

LAVINIA CLINIC LIMITED Income Statement For the year ended 28 February 2026
The company is dormant and has not traded during the year. The company received no income and incurred no expenditure in the year and therefore made neither a profit nor loss. The notes form part of these financial statements. 3

LAVINIA CLINIC LIMITED
Statement of Financial Position
As at 28 February 2026

	2026
	£	£
Called up share capital not paid		100
Net current assets		0
Total assets less current liabilities		100
Net assets		100


Capital and reserves		100

NOTES TO THE ACCOUNTS

General Information

LAVINIA CLINIC LIMITED is a private company, limited by shares, registered in England and Wales, registration number 15513621, registration address 68a Maryland, Hatfield, AL10 8DU.

The presentation currency is £ sterling.

1.

Accounting policies

Significant accounting policies

Statement of compliance

These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling which is the functional currency of the company.

Going concern basis

The directors believe that the company is experiencing good levels of sales growth and profitability, and that it is well placed to manage its business risks successfully. Accordingly, they have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing the financial statements.

2.

Share Capital

Allotted, called up and fully paid	2026 £
100 Class A shares of £1.00 each	100
	100

3.	Average number of employees Average number of employees during the year was 0.

For the year ended 28 February 2026 the company was entitled to exemption from audit under Section 480 of the Companies Act 2006 relating to dormant companies.

Director's responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime.

The financial statements were approved by the director on 28 August 2026 and were signed by:

--------------------------------
Bilal BASEL
Director

4

Registered Number: 15513621
England and Wales
LAVINIA CLINIC LIMITED

Dormant Accounts

Period of accounts Start date: 01 March 2025 End date: 28 February 2026